BRIEF published on 03/26/2026 at 07:35, 5 months ago HENSOLDT Releases 2025 Annual Report, Surpassing Growth Expectations HENSOLDT Geopolitical Tensions 2025 Annual Report Defense Solutions Growth And Transformation
PRESS RELEASE published on 03/26/2026 at 07:30, 5 months ago HENSOLDT publishes its 2025 Annual Report HENSOLDT publishes its 2025 Annual Report demonstrating profitable growth and strong competitive position amidst geopolitical challenges. CEO and CFO highlight key achievements and future strategies Profitable Growth HENSOLDT Defence Solutions 2025 Annual Report Geopolitical Landscape
BRIEF published on 03/05/2026 at 13:11, 5 months 21 days ago HENSOLDT Acquires Nedinsco to Enhance European Market Position European Market HENSOLDT Defense Acquisition Nedinsco Technological Expansion
PRESS RELEASE published on 03/05/2026 at 13:06, 5 months 21 days ago HENSOLDT acquires Nedinsco and expands its European presence HENSOLDT acquires Dutch optronics specialist Nedinsco, expanding its European presence. Acquisition boosts technological capabilities and innovation in the defence market Acquisition HENSOLDT Defence Market European Presence Nedinsco
BRIEF published on 02/26/2026 at 06:35, 6 months ago HENSOLDT Reports Record Growth in 2025 Revenue Growth Profitability Order Intake Dividend Proposal Book-to-Bill Ratio
PRESS RELEASE published on 02/26/2026 at 06:30, 6 months ago Financial year 2025: HENSOLDT achieves record order intake and confirms structural growth path HENSOLDT achieves record order intake of EUR 4,710 million in 2025 financial year, with revenue growing to EUR 2,455 million and a proposed dividend increase to EUR 0.55 per share Financial Results Dividend Proposal Growth Path HENSOLDT Record Order Intake
BRIEF published on 02/24/2026 at 18:05, 6 months 2 days ago HENSOLDT Extends CEO Oliver Dörre's Tenure Until 2031 Contract Extension Strategic Growth HENSOLDT AG CEO Oliver Dörre Defence Industry
PRESS RELEASE published on 02/24/2026 at 18:00, 6 months 2 days ago HENSOLDT extends CEO Oliver Dörre's contract until end of 2031 HENSOLDT AG extends CEO Oliver Dörre's contract until end of 2031, focusing on continuity, growth, and strategic transformation Contract Extension CEO HENSOLDT AG Strategic Transformation Oliver Dörre
BRIEF published on 11/11/2025 at 13:05, 9 months 15 days ago HENSOLDT's Strategic Advancements at Capital Markets Day 2025 Revenue Growth Financial Forecast HENSOLDT Industrial Scaling Software-Defined Defense
PRESS RELEASE published on 11/11/2025 at 13:00, 9 months 15 days ago Capital Markets Day: HENSOLDT makes significant progress in capacity expansion and Software-Defined Defence HENSOLDT reports progress in capacity expansion and software-defined defence during its Capital Markets Day 2025, aiming for substantial growth and efficiency improvements Growth Capital Markets Day Capacity Expansion HENSOLDT Software-defined Defence
Published on 08/26/2026 at 17:40, 2 hours 18 minutes ago Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures
Published on 08/26/2026 at 15:25, 4 hours 33 minutes ago CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026
Published on 08/26/2026 at 15:00, 4 hours 58 minutes ago Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 4 hours 58 minutes ago Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 14:30, 5 hours 28 minutes ago Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update
Published on 08/26/2026 at 18:44, 1 hour 13 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 1 hour 18 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 1 hour 28 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 1 hour 58 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 17:45, 2 hours 13 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 July 2026.
Published on 08/26/2026 at 18:02, 1 hour 56 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 1 hour 58 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 2 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 2 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
